265 related articles for article (PubMed ID: 21569741)
1. Pseudoephedrine may cause "pigmenting" fixed drug eruption.
Ozkaya E; Elinç-Aslan MS
Dermatitis; 2011 May; 22(3):E7-9. PubMed ID: 21569741
[TBL] [Abstract][Full Text] [Related]
2. Nonpigmenting fixed drug eruption due to pseudoephedrine.
Vidal C; Prieto A; Pérez-Carral C; Armisén M
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):309-10. PubMed ID: 9564979
[TBL] [Abstract][Full Text] [Related]
3. Non-pigmenting fixed drug eruption with mixed features of acute generalized exanthematous pustulosis induced by pseudoephedrine: a case report.
Fukuda R; Ouchi T; Hirai I; Funakoshi T; Honda A; Tanese K; Tanikawa A; Amagai M; Takahashi H
Contact Dermatitis; 2017 Aug; 77(2):123-126. PubMed ID: 28703347
[No Abstract] [Full Text] [Related]
4. Bullous nonpigmenting multifocal fixed drug eruption due to pseudoephedrine in a combination drug: clinical and diagnostic observations.
Bellini V; Bianchi L; Hansel K; Finocchi R; Stingeni L
J Allergy Clin Immunol Pract; 2016; 4(3):542-4. PubMed ID: 26795640
[No Abstract] [Full Text] [Related]
5. Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline.
Shelley WB; Shelley ED
J Am Acad Dermatol; 1987 Sep; 17(3):403-7. PubMed ID: 2958519
[TBL] [Abstract][Full Text] [Related]
6. Nonpigmenting solitary fixed drug eruption caused by a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine.
Matsumoto K; Mikoshiba H; Saida T
J Am Acad Dermatol; 2003 Apr; 48(4):628-30. PubMed ID: 12664035
[TBL] [Abstract][Full Text] [Related]
7. Nonpigmenting solitary fixed drug eruption caused by pseudoephedrine hydrochloride.
Hindioğlu U; Sahin S
J Am Acad Dermatol; 1998 Mar; 38(3):499-500. PubMed ID: 9520039
[No Abstract] [Full Text] [Related]
8. Dose-dependent, non-pigmenting fixed drug eruption with eczematous lesions induced by bosutinib: case report.
Youh J; Yamaguchi Y; Kawamura T; Hoshina D
Pan Afr Med J; 2023; 46():95. PubMed ID: 38405098
[TBL] [Abstract][Full Text] [Related]
9. Fixed drug eruption due to ciprofloxacin.
Dhar S; Sharma VK
Br J Dermatol; 1996 Jan; 134(1):156-8. PubMed ID: 8745905
[TBL] [Abstract][Full Text] [Related]
10. Fixed drug eruption from piroxicam.
Cuerda Galindo E; Goday Buján JJ; García Silva JM; Martínez W; Verea Hernando M; Fonseca E
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):586-7. PubMed ID: 15324401
[TBL] [Abstract][Full Text] [Related]
11. Drug related clinical pattern in fixed drug eruption.
Ozkaya-Bayazit E; Bayazit H; Ozarmagan G
Eur J Dermatol; 2000 Jun; 10(4):288-91. PubMed ID: 10846256
[TBL] [Abstract][Full Text] [Related]
12. [Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis].
Huynh VA; Lungoci E; Villani A; Ben Said B; Hacard F; Nicolas JF; Bérard F
Ann Dermatol Venereol; 2016 Dec; 143(12):852-855. PubMed ID: 27080820
[TBL] [Abstract][Full Text] [Related]
13. [Toxic dermatitis caused by pseudoephedrine: apropos of a case].
Fontaine JF; Lavaud F; Deslée G; Caillet MJ; Lebargy F
Allerg Immunol (Paris); 2002 Sep; 34(7):230-2. PubMed ID: 12389444
[TBL] [Abstract][Full Text] [Related]
14. Postcoital fixed drug eruption in a man sensitive to trimethoprim-sulphamethoxazole.
Gruber F; Stasić A; Lenković M; Brajac I
Clin Exp Dermatol; 1997 May; 22(3):144-5. PubMed ID: 9425695
[TBL] [Abstract][Full Text] [Related]
15. Nonpigmenting and pigmenting fixed drug eruptions due to clarithromycin.
Asano A; Sowa-Osako J; Umekoji-Hayashi A; Teramae A; Fukai K; Tsuruta D
Contact Dermatitis; 2021 Nov; 85(5):590-591. PubMed ID: 34129244
[No Abstract] [Full Text] [Related]
16. Unilateral non-pigmenting fixed drug eruption associated with cotrimoxazole.
Rasi A; Khatami A
Dermatol Online J; 2006 Oct; 12(6):12. PubMed ID: 17083892
[TBL] [Abstract][Full Text] [Related]
17. Neutrophilic fixed drug eruption, a histopathologic variant or an expected finding?-A report of two cases and review of the literature.
Theroux Z; Gardner J; Ortiz E; Kosik G; Junkins-Hopkins J
J Cutan Pathol; 2023 Oct; 50(10):884-889. PubMed ID: 37403191
[TBL] [Abstract][Full Text] [Related]
18. Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives.
Cravo M; Gonçalo M; Figueiredo A
Int J Dermatol; 2007 Jul; 46(7):760-2. PubMed ID: 17614812
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Drug Reactions: typical and atypical cases of a distinctive drug reaction.
Hernandez-Aragues I; Vilas-Boas P; Bergón-Sendín M; Parra-Blanco V; Simal-Gómez G
Eur J Dermatol; 2018 Jun; 28(3):427-429. PubMed ID: 30106000
[No Abstract] [Full Text] [Related]
20. Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization.
Teraki Y; Shiohara T
Dermatology; 2004; 209(1):29-32. PubMed ID: 15237264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
